We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Pfizer/BioNTech COVID-19 Vaccine More Than 90 Percent Effective, Early Data Reveals
Pfizer/BioNTech COVID-19 Vaccine More Than 90 Percent Effective, Early Data Reveals
Pfizer and BioNTech have pulled ahead to become the frontrunners in the race for a COVID-19 vaccine, announcing that the first interim analysis from their late-stage trial showed the candidate was more than 90 percent effective.